import { createHash } from 'node:crypto';

/**
 * Series A Investor Deal Room Engine
 * Assembles institutional term sheet, valuation metrics, cap table,
 * non-dilutive grant stacking leverage, and VC outreach execution parameters.
 */
export class SeriesAInvestorDealRoomEngine {
  constructor() {
    this.dealTerms = {
      roundName: 'Series A Preferred Equity',
      targetRaiseEur: 5000000,
      preMoneyValuationEur: 50000000,
      postMoneyValuationEur: 55000000,
      dilutionPercentage: 9.09,
      leadInvestorTicketEur: 2500000,
      coInvestorTicketsEur: [1000000, 1000000, 500000],
      nonDilutiveGrantStackingEur: 75000000,
      grantMatchingMultiplier: '15x Grant-to-Equity Leverage Ratio'
    };

    this.corporateEntities = [
      { name: 'Brehon AI Technologies', jurisdiction: 'Sion, Valais, Switzerland', focus: 'R&D, WASM Ballistics, POL-002 AST Engine, 150% Valais R&D Super-Deduction' },
      { name: 'Brehon AI Solutions Ltd', jurisdiction: 'Dublin / Kinsale, Ireland (CRO 790337)', focus: 'B2B Enterprise SaaS Delivery, 12.5% Tax Rate, EIC Accelerator Lead' },
      { name: 'Brehon AI Recruitment / BAIR OS', jurisdiction: 'Belfast HQ, NI / St Andrews Office, UK', focus: 'Talent Acquisition OS for PGA Pros & Biopharma Validation Engineers' },
      { name: 'A.Ward Publications', jurisdiction: 'Ireland / UK (Nielsen 978-1-918501)', focus: 'Master IP Vault, Patent WO 2026/150385 (PCT/IE2025/050001), Trademarks' }
    ];

    this.top5VcTargets = [
      { name: 'Veritas SportsTech Ventures', focus: 'Sports Performance & Biometrics', location: 'London / Zurich', targetTicket: '€2.5M Lead' },
      { name: 'Alpine Horizon Capital', focus: 'Deep-Tech & Swiss Engineering', location: 'Geneva / Zurich', targetTicket: '€1.0M Co-Lead' },
      { name: 'Atlantic Bridge Capital', focus: 'US-EU Transnational Scale-up', location: 'Dublin / Palo Alto', targetTicket: '€1.0M Co-Lead' },
      { name: 'EQT Ventures', focus: 'Enterprise SaaS & AI Platforms', location: 'Stockholm / London', targetTicket: '€500k Syndicate' },
      { name: 'MIG Capital', focus: 'Biomedical & High-Performance Tech', location: 'Munich', targetTicket: '€500k Syndicate' }
    ];
  }

  generateDealRoomManifest() {
    const timestamp = new Date().toISOString();
    const payload = `${this.dealTerms.targetRaiseEur}:${this.dealTerms.preMoneyValuationEur}:${timestamp}`;
    const dealRoomHash = createHash('sha256').update(payload).digest('hex');

    return {
      status: 'INVESTOR_DEAL_ROOM_LIVE',
      dealTerms: this.dealTerms,
      totalCorporateEntities: this.corporateEntities.length,
      topVcTargetsCount: this.top5VcTargets.length,
      dealRoomHash
    };
  }
}
